FDA Cracks Down on Obesity Drug
Citing safety concerns, the U.S. Food and Drug Administration (FDA has placed restrictions on the use of GlaxoSmithKline’s Avandia (generic name “rosiglitazone”), a prescription drug that is marketed for treating type 2 diabetes. GSK’s other drugs that contain rosiglitazone, Avandamet (with metformin) and Avandaryl (with glimepiride), have also been restricted. The FDA has proposed requiring [...]
Can Diabetes Treatment Trigger Eating Disorders?
Diabetics can easily find themselves in a sticky situation when efforts to manage their disease through their food intake and weight find them a prime target for an eating disorder. According to research conducted by Dr. Deborah Young-Hyman, pediatric psychologist at the Medical College of Georgia’s Georgia Prevention Institute, attempts to maintain healthy blood sugar [...]
